Reuters
Published Oct 08, 2021 06:21PM ET
Updated Oct 08, 2021 09:20PM ET
By David Shepardson
WASHINGTON (Reuters) -The United States will accept the use by international visitors of COVID-19 vaccines authorized by U.S. regulators or the World Health Organization, the Centers for Disease Control and Prevention said late on Friday.
On Sept. 20, the White House announced the United States in November would lift travel restrictions on air travelers from 33 countries including China, India, Brazil and most of Europe who are fully vaccinated against COVID-19. It did not specify then which vaccines would be accepted.
A CDC spokeswoman told Reuters Friday, "Six vaccines that are FDA authorized/approved or listed for emergency use by WHO will meet the criteria for travel to the U.S."
Late on Friday, the CDC said that "earlier this week, to help them prepare their systems we informed airlines" of the vaccines that would be accepted and added "CDC will release additional guidance and information as the travel requirements are finalized."
Airlines for America, a trade group representing American Airlines (NASDAQ:AAL) Co, Delta Air Lines (NYSE:DAL), United Airlines and others, said it was "pleased by the CDC's decision to approve a list of authorized vaccinations for travelers entering the U.S. We look forward to working with the administration to implement this new global vaccine and testing framework by early November 2021."
Some countries had pressed the Biden administration to accept WHO-approved vaccines, since the U.S. Food and Drug Administration authorized vaccines are not widely used in all countries.
The United States will admit fully vaccinated air travelers from the 26 so-called Schengen countries in Europe as well as Britain, Ireland, China, India, South Africa, Iran and Brazil. The unprecedented U.S. restrictions have barred most non-U.S. citizens who were in those countries within the past 14 days.
The new COVID-19 vaccine requirements will now apply to nearly all foreign nationals flying to the United States - including those not subject to the prior restrictions.
The CDC must still finalize and publish new contract tracing rules for international visitors, which it sent to the White House for review on Sept. 15.
The CDC must also detail rules for exceptions, which include children not yet eligible for shots, as well as for visitors from countries where vaccines are not widely available. The administration must also decide whether to admit visitors part of COVID-19 clinical trials or have recently contracted COVID-19 and are not yet eligible for vaccination.
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.